What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer.
Emma DunlopAimee FergusonTanja MuellerKelly BaillieJulie ClarkeJennifer LaskeyAmanj KurdiOlivia WuRob JonesHilary GlenMarion BenniePublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
This study provides insight into the similarities and differences between what clinicians and patients think is important when discussing the impact of cancer medicines on HRQoL. Future research should involve exploring the potential for consistency of medicines PROMs across different cancer types to support patient-clinician communication and drive improvements in care.
Keyphrases
- prostate cancer
- end stage renal disease
- papillary thyroid
- newly diagnosed
- ejection fraction
- palliative care
- patient reported outcomes
- chronic kidney disease
- squamous cell
- healthcare
- peritoneal dialysis
- clinical trial
- squamous cell carcinoma
- randomized controlled trial
- study protocol
- radical prostatectomy
- lymph node metastasis
- risk assessment
- clinical practice